These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 16487266

  • 21. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S, Messerli FH, Cohen JD, Bacher PH, Sleight P, Mancia G, Kowey P, Zhou Q, Champion A, Pepine CJ, INVEST Investigators.
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [Abstract] [Full Text] [Related]

  • 22. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up.
    Almgren T, Wilhelmsen L, Samuelsson O, Himmelmann A, Rosengren A, Andersson OK.
    J Hypertens; 2007 Jun; 25(6):1311-7. PubMed ID: 17563546
    [Abstract] [Full Text] [Related]

  • 23. Comparison of arterial functional evaluations as a predictor of cardiovascular events in hypertensive patients: the Non-Invasive Atherosclerotic Evaluation in Hypertension (NOAH) study.
    Terai M, Ohishi M, Ito N, Takagi T, Tatara Y, Kaibe M, Komai N, Rakugi H, Ogihara T.
    Hypertens Res; 2008 Jun; 31(6):1135-45. PubMed ID: 18716361
    [Abstract] [Full Text] [Related]

  • 24. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction.
    Selcuk H, Temizhan A, Selcuk MT, Sen T, Maden O, Tekeli S, Sasmaz A.
    Coron Artery Dis; 2009 Sep; 20(6):370-5. PubMed ID: 19609207
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Ibsen H, Kjeldsen SE, Lyle PA, Devereux RB.
    J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure.
    Johansson M, Gao SA, Friberg P, Annerstedt M, Carlström J, Ivarsson T, Jensen G, Ljungman S, Mathillas O, Nielsen FD, Strömbom U.
    J Hypertens; 2007 Jan; 25(1):163-8. PubMed ID: 17143188
    [Abstract] [Full Text] [Related]

  • 32. Short- and long-term risk of cardiovascular events in white-coat hypertension.
    Pierdomenico SD, Lapenna D, Di Mascio R, Cuccurullo F.
    J Hum Hypertens; 2008 Jun; 22(6):408-14. PubMed ID: 18288127
    [Abstract] [Full Text] [Related]

  • 33. Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events.
    de Jonge P, van den Brink RH, Spijkerman TA, Ormel J.
    J Am Coll Cardiol; 2006 Dec 05; 48(11):2204-8. PubMed ID: 17161246
    [Abstract] [Full Text] [Related]

  • 34. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V, Winkler K, Drechsler C, Lilienthal J, März W, Wanner C, German Diabetes and Dialysis Study Investigators.
    Am J Kidney Dis; 2009 Nov 05; 54(5):902-11. PubMed ID: 19781835
    [Abstract] [Full Text] [Related]

  • 35. Prognostic value of nocturnal blood pressure reduction in resistant hypertension.
    Muxfeldt ES, Cardoso CR, Salles GF.
    Arch Intern Med; 2009 May 11; 169(9):874-80. PubMed ID: 19433699
    [Abstract] [Full Text] [Related]

  • 36. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
    Lemaitre RN, Heckbert SR, Sotoodehnia N, Bis JC, Smith NL, Marciante KD, Hindorff LA, Lange LA, Lumley TS, Rice KM, Wiggins KL, Psaty BM.
    Am J Hypertens; 2008 Mar 11; 21(3):290-6. PubMed ID: 18219297
    [Abstract] [Full Text] [Related]

  • 37. The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension.
    Wahlstrand B, Orho-Melander M, Delling L, Kjeldsen S, Narkiewicz K, Almgren P, Hedner T, Melander O.
    J Hypertens; 2009 Apr 11; 27(4):769-73. PubMed ID: 19293724
    [Abstract] [Full Text] [Related]

  • 38. Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome.
    van Oijen MG, Claessen BE, Clappers N, van Schaik A, Laheij RJ, Jansen JB, Peters WH, Verheugt FW.
    Am J Cardiol; 2008 Jul 15; 102(2):135-9. PubMed ID: 18602509
    [Abstract] [Full Text] [Related]

  • 39. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C, Sudre A, Lemesle G, Maréchaux S, Broucqsault D, Hennache B, Bauters C, Lablanche JM.
    Cardiovasc Revasc Med; 2009 Jul 15; 10(3):144-50. PubMed ID: 19595394
    [Abstract] [Full Text] [Related]

  • 40. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G, Hedblad B, Janzon L, Lindgärde F.
    Eur J Cardiovasc Prev Rehabil; 2007 Jun 15; 14(3):392-7. PubMed ID: 17568238
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.